Cargando…

Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study

BACKGROUND: Proliferative activity (Ki-67 Labelling Index) in breast cancer increasingly serves as an additional tool in the decision for or against adjuvant chemotherapy in midrange hormone receptor positive breast cancer. Ki-67 Index has been previously shown to suffer from high inter-observer var...

Descripción completa

Detalles Bibliográficos
Autores principales: Varga, Zsuzsanna, Cassoly, Estelle, Li, Qiyu, Oehlschlegel, Christian, Tapia, Coya, Lehr, Hans Anton, Klingbiel, Dirk, Thürlimann, Beat, Ruhstaller, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401515/
https://www.ncbi.nlm.nih.gov/pubmed/25885288
http://dx.doi.org/10.1371/journal.pone.0123435
_version_ 1782367153287069696
author Varga, Zsuzsanna
Cassoly, Estelle
Li, Qiyu
Oehlschlegel, Christian
Tapia, Coya
Lehr, Hans Anton
Klingbiel, Dirk
Thürlimann, Beat
Ruhstaller, Thomas
author_facet Varga, Zsuzsanna
Cassoly, Estelle
Li, Qiyu
Oehlschlegel, Christian
Tapia, Coya
Lehr, Hans Anton
Klingbiel, Dirk
Thürlimann, Beat
Ruhstaller, Thomas
author_sort Varga, Zsuzsanna
collection PubMed
description BACKGROUND: Proliferative activity (Ki-67 Labelling Index) in breast cancer increasingly serves as an additional tool in the decision for or against adjuvant chemotherapy in midrange hormone receptor positive breast cancer. Ki-67 Index has been previously shown to suffer from high inter-observer variability especially in midrange (G2) breast carcinomas. In this study we conducted a systematic approach using different Ki-67 assessments on large tissue sections in order to identify the method with the highest reliability and the lowest variability. MATERIALS AND METHODS: Five breast pathologists retrospectively analyzed proliferative activity of 50 G2 invasive breast carcinomas using large tissue sections by assessing Ki-67 immunohistochemistry. Ki-67-assessments were done on light microscopy and on digital images following these methods: 1) assessing five regions, 2) assessing only darkly stained nuclei and 3) considering only condensed proliferative areas (‘hotspots’). An individual review (the first described assessment from 2008) was also performed. The assessments on light microscopy were done by estimating. All measurements were performed three times. Inter-observer and intra-observer reliabilities were calculated using the approach proposed by Eliasziw et al. Clinical cutoffs (14% and 20%) were tested using Fleiss’ Kappa. RESULTS: There was a good intra-observer reliability in 5 of 7 methods (ICC: 0.76–0.89). The two highest inter-observer reliability was fair to moderate (ICC: 0.71 and 0.74) in 2 methods (region-analysis and individual-review) on light microscopy. Fleiss’-kappa-values (14% cut-off) were the highest (moderate) using the original recommendation on light-microscope (Kappa 0.58). Fleiss’ kappa values (20% cut-off) were the highest (Kappa 0.48 each) in analyzing hotspots on light-microscopy and digital-analysis. No methodologies using digital-analysis were superior to the methods on light microscope. CONCLUSION: Our results show that all methods on light-microscopy for Ki-67 assessment in large tissue sections resulted in a good intra-observer reliability. Region analysis and individual review (the original recommendation) on light-microscopy yielded the highest inter-observer reliability. These results show slight improvement to previously published data on poor-reproducibility and thus might be a practical-pragmatic way for routine assessment of Ki-67 Index in G2 breast carcinomas.
format Online
Article
Text
id pubmed-4401515
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-44015152015-04-21 Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study Varga, Zsuzsanna Cassoly, Estelle Li, Qiyu Oehlschlegel, Christian Tapia, Coya Lehr, Hans Anton Klingbiel, Dirk Thürlimann, Beat Ruhstaller, Thomas PLoS One Research Article BACKGROUND: Proliferative activity (Ki-67 Labelling Index) in breast cancer increasingly serves as an additional tool in the decision for or against adjuvant chemotherapy in midrange hormone receptor positive breast cancer. Ki-67 Index has been previously shown to suffer from high inter-observer variability especially in midrange (G2) breast carcinomas. In this study we conducted a systematic approach using different Ki-67 assessments on large tissue sections in order to identify the method with the highest reliability and the lowest variability. MATERIALS AND METHODS: Five breast pathologists retrospectively analyzed proliferative activity of 50 G2 invasive breast carcinomas using large tissue sections by assessing Ki-67 immunohistochemistry. Ki-67-assessments were done on light microscopy and on digital images following these methods: 1) assessing five regions, 2) assessing only darkly stained nuclei and 3) considering only condensed proliferative areas (‘hotspots’). An individual review (the first described assessment from 2008) was also performed. The assessments on light microscopy were done by estimating. All measurements were performed three times. Inter-observer and intra-observer reliabilities were calculated using the approach proposed by Eliasziw et al. Clinical cutoffs (14% and 20%) were tested using Fleiss’ Kappa. RESULTS: There was a good intra-observer reliability in 5 of 7 methods (ICC: 0.76–0.89). The two highest inter-observer reliability was fair to moderate (ICC: 0.71 and 0.74) in 2 methods (region-analysis and individual-review) on light microscopy. Fleiss’-kappa-values (14% cut-off) were the highest (moderate) using the original recommendation on light-microscope (Kappa 0.58). Fleiss’ kappa values (20% cut-off) were the highest (Kappa 0.48 each) in analyzing hotspots on light-microscopy and digital-analysis. No methodologies using digital-analysis were superior to the methods on light microscope. CONCLUSION: Our results show that all methods on light-microscopy for Ki-67 assessment in large tissue sections resulted in a good intra-observer reliability. Region analysis and individual review (the original recommendation) on light-microscopy yielded the highest inter-observer reliability. These results show slight improvement to previously published data on poor-reproducibility and thus might be a practical-pragmatic way for routine assessment of Ki-67 Index in G2 breast carcinomas. Public Library of Science 2015-04-17 /pmc/articles/PMC4401515/ /pubmed/25885288 http://dx.doi.org/10.1371/journal.pone.0123435 Text en © 2015 Varga et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Varga, Zsuzsanna
Cassoly, Estelle
Li, Qiyu
Oehlschlegel, Christian
Tapia, Coya
Lehr, Hans Anton
Klingbiel, Dirk
Thürlimann, Beat
Ruhstaller, Thomas
Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title_full Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title_fullStr Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title_full_unstemmed Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title_short Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study
title_sort standardization for ki-67 assessment in moderately differentiated breast cancer. a retrospective analysis of the sakk 28/12 study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401515/
https://www.ncbi.nlm.nih.gov/pubmed/25885288
http://dx.doi.org/10.1371/journal.pone.0123435
work_keys_str_mv AT vargazsuzsanna standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT cassolyestelle standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT liqiyu standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT oehlschlegelchristian standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT tapiacoya standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT lehrhansanton standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT klingbieldirk standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT thurlimannbeat standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study
AT ruhstallerthomas standardizationforki67assessmentinmoderatelydifferentiatedbreastcanceraretrospectiveanalysisofthesakk2812study